Rising Demand For Minimally Invasive Procedures Fueling The Growth Of The Market Due To Faster Recovery And Reduced Complications: A Key Driver Powering Arteriovenous Malformations Market Growth In 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Current Arteriovenous Malformations Market Size and Its Estimated Growth Rate?
The market size for arteriovenous malformations has robustly expanded in the past few years. It is expected to surge from $2.88 billion in 2024 to $3.11 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The growth experienced during this historical period can be credited to the escalating incidence of arteriovenous malformations and neurological or brain disorders, growing demand for improved treatments for uncommon diseases, increased government backing for research and development, along with an upward trend in the business sector.

Expectations are high that the arteriovenous malformations market will undergo robust growth in the coming years, eventually reaching a $4.13 billion valuation in 2029, representing a compound annual growth rate (CAGR) of 7.4%. This predicted growth during the forecast period can be credited to factors like increased use of gene therapy, growing necessity for enhanced medical technology, demand for higher quality healthcare, heightened usage of neurological drugs, and growth parallel to the aging population. Key trends expected in the forecast period include improvements in treatment procedures, progress in medical technology, development in microsurgical methods, breakthroughs in catheter technology, and advancement towards minimally invasive surgeries.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21888

How Are Emerging Segments Shaping the Arteriovenous Malformations Market Landscape?
The arteriovenous malformations market covered in this report is segmented -

1) By Type: True Arteriovenous Malformation, Occult Or Cryptic, Cavernous Malformations, Venous Malformation, Hemangioma, Dural Fistula, Other Types
2) By Diagnosis: Physical examination, Brain Scans, Other Diagnosis
3) By Treatment: Endovascular Embolization, Neurosurgery
4) By Age Group: Adult Patients, Pediatric Patients
5) By End-User: Hospitals And Clinics, Research laboratories, Other End-Users

Subsegmentss:

1) By True Arteriovenous Malformation Type: Pial AVMs, Spinal AVMs, Brain AVMs, Extremity AVMs, Visceral AVMs
2) By Occult or Cryptic Type: Micro-AVMs, Hidden AVMs, Asymptomatic AVMs, Deep-Seated AVMs, Small-Scale AVMs
3) By Cavernous Malformations Type: Cerebral Cavernous Malformations (CCMs), Spinal Cavernous Malformations, Familial Cavernous Malformations, Solitary Cavernous Malformations, Multiple Cavernous Malformations
4) By Venous Malformation Type: Superficial Venous Malformations, Deep Venous Malformations, Mixed Venous Malformations, Syndromic Venous Malformations, Blue Rubber Bleb Nevus Syndrome
5) By Hemangioma Type: Infantile Hemangiomas, Capillary Hemangiomas, Lobular Capillary Hemangiomas, Cavernous Hemangiomas, Compound Hemangiomas
6) By Dural Fistula Type: Cranial Dural Arteriovenous Fistula (dAVF), Spinal Dural Arteriovenous Fistula, Direct Dural AV Fistula, Indirect Dural AV Fistula, High-Flow Dural Fistula
7) By Other Types: Lymphatic Malformations, Mixed Vascular Malformations, Arteriovenous Aneurysms, Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs, Rare Congenital AVMs

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21888&type=smp

Which Growth Factors Are Influencing Arteriovenous Malformations Market Expansion?
The growth of the arteriovenous malformations market in the future is projected to be driven by a surge in the demand for minimally invasive procedures. These procedures, implemented through tiny incisions or catheter-based techniques, lead to reduced trauma, shorter duration of recovery and lower complications. The reason for the growing preference for such surgeries can be attributed to quicker recovery periods due to lesser trauma inflicted on the tissues and shorter healing times. As a result, patients resume their everyday routines faster in comparison to traditional open surgeries. Such procedures being favored by healthcare providers and patients alike, arteriovenous malformations (AVMs) contribute to the trend by facilitating sophisticated techniques, such as endovascular embolization. This technique relies on catheters and image-guided interventions to decrease aberrant blood flow without necessitating open surgery, resulting in reduced risks, shorter recovery timeframes and better patient outcomes. For instance, the American Society of Plastic Surgeons reports that a total of 25,442,640 cosmetic minimally invasive procedures were carried out in September 2023. This denotes an increase from 23,672,269 procedures in 2022, a growth of 7% in minimally invasive treatments for both genders in 2023. Consequently, the surge in minimally invasive procedures is driving the expansion of the arteriovenous malformations market. The accelerating development of the arteriovenous malformations market in the future can also be linked to rising investments in the biotechnology field. Biotechnology concerns the application of biological processes, organisms or systems to create healthcare products and technologies. The escalating investments in biotechnology can be attributed to breakthroughs in gene editing technologies like CRISPR that open up avenues for intricate genetic modifications with medical innovations. Arteriovenous malformations contribute in their own way to this trend by boosting medical imaging, gene therapy and minimally invasive treatments. This helps to usher in biotechnology-based solutions like targeted drug delivery, biomaterials for vascular repair and diagnostics aided by Artificial Intelligence. As an example, The BioIndustry Association (BIA), a UK-based trade association for innovative life sciences and the biotech industry, declared in August 2024 that the UK's life sciences and biotechnology sector experienced its most lucrative investment quarter since the pandemic in 2024. It acquired $2.55 billion in the first two quarters of the year, crossing the $2.32 billion secured in 2023. Hence, the escalating investments in biotechnology serve to propel the growth of the arteriovenous malformations market.

Who Are the Dominant Players Across Different Arteriovenous Malformations Market Segments?
Major companies operating in the arteriovenous malformations market are Johnson And Johnson Services Inc., Siemens AG, Medtronic Plc, Koninklijke Philips N V, Stryker Corporation, GE Healthcare Technologies Inc, Cedars-Sinai, Penn Medicine, Terumo Corporation, Eisai Co Ltd, Cook Medical LLC, Elekta AB, Merit Medical Systems Inc., Penumbra Inc., Max Healthcare, RWJBarnabas Health, Balt LLC, Booking Health GmbH, Duke University Health System, Shape Memory Medical Inc.

What Are the Latest Developing Trends in the Arteriovenous Malformations Market?
Prominent corporations engaged in the arteriovenous malformations sector are prioritizing technological innovations, including liquid embolic system procedural kits, to streamline treatment methods and enhance patient results. The liquid embolic system procedural kit pertains to a ready-to-use, sterilized pack that includes all vital components required to administer liquid embolic agents to address vascular irregularities like arteriovenous malformations (AVMs). For example, in March 2024, CERENOVUS Inc., an American neurovascular care firm part of Johnson and Johnson MedTech, unveiled the TRUFILL n-BCA liquid embolic system procedural kit. This kit incorporates two configurations and requisite accessories to prepare and administer the n-BCA liquid embolic system in a sterilized package, thereby facilitating procedure preparation for treating cerebral arteriovenous malformations (AVMs).

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/arteriovenous-malformations-global-market-report

Which Geographic Regions Are Expected to Dominate the Arteriovenous Malformations Market in the Coming Years?
North America was the largest region in the arteriovenous malformations market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriovenous malformations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Arteriovenous Malformations Market?
2. What is the CAGR expected in the Arteriovenous Malformations Market?
3. What Are the Key Innovations Transforming the Arteriovenous Malformations Industry?
4. Which Region Is Leading the Arteriovenous Malformations Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.